International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Oncol Lett 27: [Related article:] 22, 2024; DOI: 10.3892/ol.2023.14154
Following the publication of the above paper, the authors have submitted a request to the Editorial Office to retract the article on account of a problem regarding ethical approval. The analysis was performed on patients who received anamorelin between July 2021 and November 2022; however, upon re-examining the ethical approval statement, it was stated to be applicable only for patients who received anamorelin between July 2021 and April 2022. Owing to this oversight on the part of the authors, patients were also included in the study over the period April-November 2022, which was not covered by the ethical approval.
Given that this problem has come to light, the Editor of Oncology Letters has agreed to the authors’ request to retract this paper from the Journal. The authors and the Editor apologize to the readership for any inconvenience caused.